State-wide surveillance of antibiotic resistance patterns and spa types of methicillin-resistant Staphylococcus aureus from blood cultures in North Rhine-Westphalia, 2011-2013

Clinical Microbiology and Infection

Volumn 21, Issue 8, 2015, Pages 750-757

  Cuny, C ^a   Layer, F ^a   Werner, G ^a   Harmsen, D ^b   Daniels Haardt, I ^c   Jurke, A ^c   Mellmann, A ^b   Witte, W ^a   Kock R ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Institute for Public Health North Rhine Westphalia   (Germany)

Author keywords

Antimicrobial resistance; Bacteraemia; Germany; Livestock; Methicillin resistant staphylococcus aureus; spa

Indexed keywords

CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; PROTEIN A; QUINOLONE DERIVATIVE; RIFAMPICIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; BROTH DILUTION; CHILD; FEMALE; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; INCIDENCE; INFANT; LIVESTOCK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPA GENE; BACTEREMIA; CLASSIFICATION; CLUSTER ANALYSIS; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PHYLOGEOGRAPHY; PRESCHOOL CHILD; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY; YOUNG ADULT;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FEMALE; GENOTYPE; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; PHYLOGEOGRAPHY; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84937395816     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.02.013     Document Type: Article

References (33)

1. European Centre for Disease Prevention and Control Annual epidemiological report: Reporting on 2011 surveillance data and 2012 epidemic intelligence data 2013, Available at:. http://www.ecdc.europa.eu/en/publications/Publications/annual-epidemiological-report-2013.pdf.
2. de Kraker M.E., Davey P.G., Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011, 8:e1001104. group Bs.
3. Grundmann H., Aanensen D.M., van den Wijngaard C.C., Spratt B.G., Harmsen D., Friedrich A.W., et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 2010, 7:e1000215.
4. Barnes S.L., Harris A.D., Golden B.L., Wasil E.A., Furuno J.P. Contribution of interfacility patient movement to overall methicillin-resistant Staphylococcus aureus prevalence levels. Infect Control Hosp Epidemiol 2011, 32:1073-1078.
5. Goering R.V., Köck R., Grundmann H., Werner G., Friedrich A.W. From theory to practice: molecular strain typing for the clinical and public health setting. Euro Surveill 2013, 18:20383.
6. Paul M., Kariv G., Goldberg E., Raskin M., Shaked H., Hazzan R., et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010, 65:2658-2665.
7. Layer F., Cuny C., Strommenger B., Werner G., Witte W. [Current data and trends on methicillin-resistant Staphylococcus aureus (MRSA)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012, 55:1377-1386.
8. Harbarth S., Martin Y., Rohner P., Henry N., Auckenthaler R., Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000, 46:43-49.
9. Harmsen D., Claus H., Witte W., Rothgänger J., Turnwald D., Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003, 41:5442-5448.
10. Hallin M., Friedrich A.W., Struelens M.J. spa typing for epidemiological surveillance of Staphylococcus aureus. Molecular Epidemiology of Microorganisms, Methods in Molecular Biology 2009, 189-202. Humana Press, a part of Springer Science+Business Media, Heidelberg, London, New York. D.A. Caugant (Ed.).
11. Mellmann A., Weniger T., Berssenbrügge C., Rothganger J., Sammeth M., Stoye J., et al. Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms. BMC Microbiol 2007, 7:98.
12. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
13. Strommenger B., Kettlitz C., Weniger T., Harmsen D., Friedrich A.W., Witte W. Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J Clin Microbiol 2006, 44:2533-2540.
14. Kehrenberg C., Cuny C., Strommenger B., Schwarz S., Witte W. Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr. Antimicrob Agents Chemother 2009, 53:779-781.
15. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
16. Van Cleef B.A., Kluytmans J.A., van Benthem B.H., Haenen A., Monen J., Daniels-Haardt I., et al. Cross border comparison of MRSA bacteraemia between The Netherlands and North Rhine-Westphalia (Germany): a cross-sectional study. PLoS One 2012, 7:e42787.
17. Lessa F.C., Mu Y., Davies J., Murray M., Lillie M., Pearson A., et al. Comparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006-2007. Clin Infect Dis 2010, 51:925-928.
18. Public Health England Quarterly Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli bacteraemia, and C. difficile infection data (up to April-June 2014) 2014, Public Health England, London.
19. Van Cleef B.A.G.L., Monnet D.L., Voss A., Krziwanek K., Allerberger F., Struelens M., et al. Livestock-associated methicillin-resistant Staphylococcus aureus from human samples, Europe, 2007. Emerg Infect Dis 2011, 17:502-505.
20. Wendlandt S., Schwarz S., Silley P. Methicillin-resistant Staphylococcus aureus: a food-borne pathogen?. Annu Rev Food Sci Technol 2013, 4:117-139.
21. Schaumburg F., Köck R., Mellmann A., Richter L., Hasenberg F., Kriegeskorte A., et al. Population dynamics among methicillin resistant Staphylococcus aureus in Germany during a 6-year period. J Clin Microbiol 2012, 50:3186-3192.
22. Köck R., Schaumburg F., Mellmann A., Koksal M., Jurke A., Becker K., et al. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany. PLoS One 2013, 8:e55040.
23. Osmon D.R., Berbari E.F., Berendt A.R., Lew D., Zimmerli W., Steckelberg J.M., et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013, 56:e1-e25.
24. Société de Pathologie Infectieuse de Langue, Collège des Universitaires de Maladies Infectieuses et Tropicales, Groupe de Pathologie Infectieuse Pédiatrique, Société Francaise d'Anésthesie et de Reanimation, Société Francaise de Chirurgie Orthopédique et Traumatologique, Société Francaise d'Hygiène Hospitalière, et al. Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis). Société de Pathologie Infectieuse de Langue Francaise. Med Mal Infect 2010, 40:185-211.
25. Witte W., Braulke C., Cuny C., Heuck D., Kresken M. Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals. Infect Control Hosp Epidemiol 2001, 22:683-686.
26. Grundmann H., Schouls L., Aanensen D.M., Pluister G., Tami A., Chlebowicz M., et al. The dynamic changes of dominant clones of Staphylococcus aureus causing bloodstream infections in the European region: Results of a second structured survey. Euro Surveill 2014, 19. pii=20987.
27. Harris S.R., Feil E.J., Holden M.T., Quail M.A., Nickerson E.K., Chantratita N., et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474.
28. Gardete S., Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest 2014, 124:2836-2840.
29. Bayer A.S., Schneider T., Sahl H.G. Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann N Y Acad Sci 2013, 1277:139-158.
30. Long K.S., Vester B. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob Agents Chemother 2012, 56:603-612.
31. Dhand A., Sakoulas G. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy. F1000 Med Rep 2012, 4:4.
32. van Hal S.J., Barbagiannakos T., Jones M., Wehrhahn M.C., Mercer J., Chen D., et al. Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns. J Antimicrob Chemother 2011, 66:2284-2287.
33. Kelley P.G., Gao W., Ward P.B., Howden B.P. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure. J Antimicrob Chemother 2011, 66:1057-1060.